GSK plc Current Service Cost Net Defined Benefit Liability Asset
GSK plc (GSK) reported Current Service Cost Net Defined Benefit Liability Asset of GBP 92.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset · last filed 2026-03-06
| Period end | Current Service Cost Net Defined Benefit Liability Asset 12 month | Current Service Cost Net Defined Benefit Liability Asset 12 month as first filed |
|---|---|---|
| 2025-12-31 | 92.00M GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | 97.00M GBP 20-F · filed 2026-03-06 | |
| 2023-12-31 | 96.00M GBP 20-F · filed 2026-03-06 | |
| 2022-12-31 | 146.00M GBP 20-F · filed 2025-03-03 | |
| 2021-12-31 | 216.00M GBP 20-F · filed 2024-03-05 | |
| 2020-12-31 | 291.00M GBP 20-F · filed 2023-03-10 | |
| 2019-12-31 | 266.00M GBP 20-F · filed 2022-03-08 | |
| 2018-12-31 | 281.00M GBP 20-F · filed 2021-03-12 | |
| 2017-12-31 | 280.00M GBP 20-F · filed 2020-03-06 | -280.00M GBP 20-F/A · filed 2018-03-20 |
| 2016-12-31 | 246.00M GBP 20-F · filed 2019-03-15 | -246.00M GBP 20-F/A · filed 2018-03-20 |
| 2015-12-31 | -254.00M GBP 20-F/A · filed 2018-03-20 |